Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $530.76 | 22 | 94.3% |
| Education | $32.27 | 1 | 5.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $198.00 | 6 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $141.82 | 3 | $0 (2021) |
| Lilly USA, LLC | $78.92 | 5 | $0 (2021) |
| AbbVie Inc. | $49.06 | 3 | $0 (2021) |
| Amgen Inc. | $21.27 | 1 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $16.95 | 1 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.59 | 1 | $0 (2017) |
| Mylan Specialty L.P. | $15.21 | 1 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.12 | 1 | $0 (2021) |
| Allergan, Inc. | $12.09 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $535.35 | 21 | Novo Nordisk Inc ($198.00) |
| 2020 | $12.09 | 1 | Allergan, Inc. ($12.09) |
| 2017 | $15.59 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($15.59) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/30/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: NEUROSCIENCE | ||||||
| 06/10/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $115.74 | General |
| Category: Diabetes | ||||||
| 06/08/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Diabetes | ||||||
| 06/02/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Bone Health | ||||||
| 05/14/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $118.60 | General |
| 05/04/2021 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 04/27/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Diabetes | ||||||
| 04/20/2021 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Diabetes | ||||||
| 03/31/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: NEUROSCIENCE | ||||||
| 03/25/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.58 | General |
| 03/24/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Neuroscience | ||||||
| 03/18/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Neuroscience | ||||||
| 03/16/2021 | Mylan Specialty L.P. | Yupelri (Drug), Perforomist | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 03/10/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: NEUROSCIENCE | ||||||
| 02/25/2021 | Novo Nordisk Inc | — | Education | In-kind items and services | $32.27 | General |
| 02/25/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Diabetes | ||||||
| 02/24/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: Diabetes | ||||||
| 02/17/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: NEUROSCIENCE | ||||||
| 02/02/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $8.64 | General |
| Category: Respiratory | ||||||
| 01/27/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: Diabetes | ||||||
| 01/20/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Neuroscience | ||||||
| 12/16/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 5 | 171 | 173 | $191,112 | $16,875 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 72 | 72 | $118,584 | $10,538 | 8.9% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 34 | 35 | $39,165 | $3,302 | 8.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 11 | 11 | $23,265 | $2,141 | 9.2% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 11 | 11 | $6,490 | $597.37 | 9.2% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 43 | 44 | $3,608 | $297.29 | 8.2% |
About Dr. Cherie Thomas, M.D
Dr. Cherie Thomas, M.D is a Emergency Medicine healthcare provider based in Benson, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982683645.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cherie Thomas, M.D has received a total of $563.03 in payments from pharmaceutical and medical device companies, with $535.35 received in 2021. These payments were reported across 23 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($530.76).
As a Medicare-enrolled provider, Thomas has provided services to 171 Medicare beneficiaries, totaling 173 services with total Medicare billing of $16,875. Data is available for 1 year (2020–2020), covering 5 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Other Specialties Emergency Medical Services, Family Medicine
- Location Benson, AZ
- Active Since 01/11/2006
- Last Updated 04/01/2021
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1982683645
Products in Payments
- RYBELSUS (Drug) $115.74
- Ozempic (Drug) $49.99
- EMGALITY (Drug) $48.67
- VRAYLAR (Drug) $46.37
- TRULICITY (Drug) $30.25
- EVENITY (Biological) $21.27
- SOLIQUA 100/33 (Biological) $16.95
- SPIRIVA (Drug) $15.59
- Yupelri (Drug) $15.21
- UBRELVY (Drug) $14.78
- TRINTELLIX (Drug) $14.12
- BREZTRI (Drug) $8.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.